Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Dec 17, 2021 5:27pm
177 Views
Post# 34242292

RE:RE:RE:RE:How much could be a buyout?

RE:RE:RE:RE:How much could be a buyout?
chry200030 wrote: Anything less than $10 a share would be disappointing. This should be worth between $30 - $50 per shares, so if we get a buyout for $15 - $25 per share, the buyer would double his money.
Patience required. 



Would love you to break this down with a valuation !

Doing some back of the envelope calculations using your numbers, is confusing (then again i am an idiot)

But using your 50.00 top end....

178 million fully diluted shares, at 50 makes this a buyout price of almost 9 billion

 

Lets forget about the fact VPT has zero sales for the MRQ, and look at the ultrasound market

 

According to M&M:

 

“The global cardiovascular ultrasound system market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, at a CAGR of 5.4% from 2016 to 2021. In this report, the global market is segmented on the basis of test type, technology, device display, end user, and region.”1

 

So you would say that VPT would sell 6x the entire global market?

Even though GE alone has only A fraction of it, cardiac 2d and 3D a fraction of that, and VPT currently NONE of it.


What am I missing?
Enlighten me 

 

1

 

https://www.marketsandmarkets.com/Market-Reports/cardiovascular-ultrasound-system-market-50389652.html

<< Previous
Bullboard Posts
Next >>